Have you been diagnosed with locally advanced head and neck squamous cell carcinoma? If so, you may be able to participate in a research study to evaluate whether pembrolizumab and olaparib given before and after chemoradiotherapy can improve 1-year progression free survival.

Up to 30% of individuals who injure their anterior cruciate ligaments (ACL) suffer another ACL injury following reconstruction surgery. Improving function of the hamstrings muscles may reduce the risk of a second ACL injury. This study will determine if a novel rehabilitation tool (local muscle vibration) improves muscle function and landing characteristics (biomechanics) that are linked to ACL injury risk. Compensation is provided.

Have you had ACL reconstruction? You may be able to participate in a research study examining how brain function might change after surgery. Compensation provided.

Do you wonder about your mobility as you age? You may be eligible to participate in a research study investigating age effects on foot-ankle mechanical power interactions with the goal to enhance foot and ankle function in aging and mobility. Compensation provided.

Have you or a family member been diagnosed with Parkinson's Disease? Would you be interested in helping researchers learn more about Parkinson's by giving a blood or saliva sample? If so, you may be eligible to participate in a research study that will utilize genetic testing to provide you more information about the possible roles of your genes in your diagnosis.

Do you have a newly diagnosed endometrial cancer? if so, you may be eligible to participate in a research study looking at the role the uterine and gut microbiomes play in endometrial cancer development and treatment.

Have you been diagnosed with multiple myeloma that has returned and needed to be treated again? If so, you may be able to take part in a research study looking at the safety of giving a new drug called REGN5458 (Linvoseltamab) to patients with relapsed/refractory multiple myeloma.

People with kidney disease that have the APOL1 risk variant are at a greater risk for developing protein in their urine and chronic kidney disease. This research study is being done to determine if the investigational drug, VX-147 can slow or stop the worsening of kidney function as well as target the underlying cause of kidney disease.

Have you or your child been diagnosed with type 1 diabetes during the past 12 months? Are you interested in helping researchers learn more about how to delay or prevent type 1 diabetes or how to treat type 1 diabetes? Join a registry to be notified of future opportunities to participate in type 1 diabetes research!